血红蛋白A1c与儿童喘控制之间的关联
Hewlett Pham1, Rachelle Koehl1, Han Woo1
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
高血红蛋白A1c (HbA1c) 水平与儿童喘控制较差相关. 这表明代谢功能障碍可能会影响喘的严重程度,特别是在非肥胖儿童中.
科学领域:
- 儿科肺病学 儿科肺病学
- 代谢健康 代谢健康
- 临床研究 临床研究
背景情况:
- 喘是一种慢性呼吸道疾病,影响全球数百万儿童.
- 代谢因素,如血红蛋白A1c (HbA1c),越来越多地被认为是它们在喘病原和恶化中的潜在作用.
- 了解代谢健康和喘控制之间的相互作用对于开发有针对性的干预措施至关重要.
研究的目的:
- 调查城市儿科队列中血红蛋白A1c (HbA1c) 水平与喘结果之间的关联.
- 确定HbA1c,长期血糖控制的标志物,是否影响喘控制,症状严重程度和恶化风险.
主要方法:
- 航空公司研究招募了164名患有喘的儿童,在基线和三个月评估HbA1c和喘结果.
- 连续分析和分类HbA1c水平 (正常与糖尿病前期).
- 通用估计方程 (GEE) 模型分析了HbA1c和喘结果之间的关系,包括问卷,螺旋计和FeNO.
主要成果:
- 通过喘治疗评估问卷 (β = -0.74,p < 0.05) 测量,发现HbA1c水平增加和喘控制的恶化之间存在显著的关联.
- 在18%的参与者中观察到HbA1c水平≥5.7% (符合糖尿病前期).
- 体重指数百分位数和HbA1c之间的相互作用表明,HbA1c与症状日和恶化风险的关联在体重指数百分位数较低的儿童中更强.
结论:
- 升高的HbA1c水平与儿童喘控制较差有关,这突显了代谢功能障碍在喘发病率中的作用.
- 这些发现表明,HbA1c可能会不成比例地影响非肥胖儿童的喘结果,而这些儿童有潜在的代谢问题.
- 对代谢途径的进一步研究是有必要的,以阐明它们对儿科喘的特定影响.
更多相关视频
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
相关概念视频
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
